Dr. Boddu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cedar St
New Haven, CT 06510Phone+1 832-396-4414
Education & Training
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2013 - 2016
Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 2013 - 2016
Osmania Medical College NTR UHSClass of 2012
Certifications & Licensure
CT State Medical License 2018 - 2026
CA State Medical License 2015 - 2019
TX State Medical License 2016 - 2019
IL State Medical License 2013 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 10 citationsTranscription elongation defects link oncogenic SF3B1 mutations to targetable alterations in chromatin landscape.Prajwal C Boddu, Abhishek K Gupta, Rahul Roy, Bárbara De La Peña Avalos, Anne Olazabal-Herrero
Molecular Cell. 2024-04-18 - 3 citationsThe FANCI/FANCD2 complex links DNA damage response to R-loop regulation through SRSF1-mediated mRNA export.Anne Olazabal-Herrero, Boxue He, Youngho Kwon, Abhishek K Gupta, Arijit Dutta
Cell Reports. 2024-01-23 - 3 citationsA phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies.Prajwal C Boddu, Jayastu Senapati, Farhad Ravandi-Kashani, Elias J Jabbour, Nitin Jain
Cancer. 2023-02-15
Abstracts/Posters
- Analysis of Factors Predictive of Risk of Transformation and Time to Transformation in Patients (pts) with Mantle Cell Lymphoma _ Cohort Study of 369 PatientsPrajwal Boddu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Diverse Landscape of TET2 Variants in MDS and AML2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Clinical and Genomic Characteristics in De Novo Blastoid/Pleomorphic (dnMCL) and Transformed Blastoid/Pleomorphic (t-MCL) Mantle Cell Lymphoma (MCL) in the Ibrutinib E...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Validation of the ELN-2017 risk classification in younger adult patients (pts) with AML.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
